Salute e Benessere

Scleroderma Market to Reach US$ 4,103.07 Million by 2033 as Biologics, Targeted…

The rising prevalence of autoimmune disorders, coupled with improved disease awareness and supportive regulatory frameworks, positions the scleroderma market for sustained growth in the next decade. The rising prevalence of autoimmune disorders, coupled with improved disease awareness and supportive regulatory frameworks, positions the scleroderma market for sustained growth in the next decade. Download Exclusive Sample Report:...
PR Newswire
01/10/2025

VERTANICAL Announces Positive Results From the VER-01 Phase 3 Program for the…

"These findings provide powerful evidence that VER-01 could transform how we care for patients with chronic lower back pain, if approved," says Prof. Charles E. Argoff, Professor of Neurology at Albany Medical College and Past President of the American Academy of Pain Medicine. "The results of the Phase 3 studies bring hope to millions living with chronic pain that, if approved, VER-01 could deliver effective pain relief while addressing key safety challenges of current…
PR Newswire
01/10/2025

Global Be Well Day: Over 120,000 Cognita Colleagues and Students Worldwide Unite…

The importance of connecting is also central to Cognita's Be Well Charter – a six-step framework for lifelong mental health informed by global research. This Charter underpins Cognita's approach to wellbeing as part of its vision for holistic education. The importance of connecting is also central toCognita'sBe Well Charter – a six-step framework for lifelong mental health informed by global research. This Charter underpins Cognita's approach to wellbeing as part of its vision for...
PR Newswire
01/10/2025

kdc/one Acquires the Business and Operations of Barony Universal to Expand…

Headquartered in Irvine, Scotland, Barony has been a premium manufacturer and global exporter of aerosols for more than three decades. The Company produces a diverse portfolio of personal and household solutions – including anti-perspirant sprays, dry shampoos, shaving foams, deodorants, and specialist fabric and air care sprays – and exports to over 30 countries. Serving major retailers and leading brands across Europe, the Middle East, Australia, and the Americas, Barony recently completed a…
PR Newswire
01/10/2025

New research by ETI reveals Brits are still getting chocolate storage wrong

And while shows like The Great British Bake Off have helped bring chocolate science into the mainstream, this year's Chocolate Week was another reminder that people still struggle with the basics. Even with greater awareness of tempering and technique, everyday habits like putting chocolate in the fridge continue to undermine its quality. And while shows likeThe Great British Bake Offhave helped bring chocolate science into the mainstream, this year's Chocolate Week was another reminder...
PR Newswire
01/10/2025

Hill's Pet Nutrition Announces 2025 Hill's Global Symposium - "Strong Science…

Registration is now open for the event, titled "Strong Science, Long Lives," which builds on Hill's foundation of research on senior pet health. Simulated live streaming of the symposium for veterinary professionals in the EMEA region, will take place on October 28-29. Attendees can access the global livestream through Hill's Veterinary Academy platform, offering free virtual access to the English-, Spanish-, and French-language feeds. Virtual registration also provides on-demand…
PR Newswire
01/10/2025

Bedsure Unveils Cosy Deals on Fan-Favourite Blankets for October Amazon Prime…

Amazon Prime Day highlights include: Amazon Prime Day highlights include: About Bedsure Founded in 2016, Bedsure is a leading home textile brand with products sold to over 40 million customers worldwide. Bedsure has over 50 bestselling home products in 8 countries and has maintained a compound growth rate of 100% for five consecutive years. While Bedsure has grown into a global company with a diverse range of products to meet various customer needs, its focus on providing...
PR Newswire
01/10/2025

Inventiva Appoints Andrew Obenshain as Chief Executive Officer

Daix (France), New York City (New York, United States), October 1, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic dysfunction-associated steatohepatitis (“MASH”), today announced the appointment of Andrew Obenshain as Chief Executive Officer (“CEO”) of the Company. Mr. Obenshain will also join the Company’s Board of Directors. He succeeds...
Nasdaq GlobeNewswire
01/10/2025

H.I.G. Capital Completes the Acquisition of France Workwear

Fabrice Shoshany, CEO of France Workwear, stated: "We are proud to join the H.I.G. family and grateful for their confidence in our strategy and commitment to our future. This partnership marks the start of a new chapter for France Workwear – one where we will strengthen our leadership in textile rental services, broaden our focus on innovation and sustainability, and continue to deliver exceptional value to our clients, partners, and employees across and beyond France. We are already…
PR Newswire
01/10/2025

SKINGRAPHICA: World First Luxury Skincare For Skinart

Unlike most skincare, which is not designed for the altered structure and pigment of tattooed skin, SKINGRAPHICA uses targeted, stage-specific formulations. Tattoos live in the dermis, and general skincare often contains ingredients that are not Ink-Safe™. These include strong resurfacing acids, high-strength retinoids, and harsh peels, which can thin the skin, accelerate cell turnover, and blur or mute tattoo color. SKINGRAPHICA avoids these harsh, ink-compromising actives, engineering every…
PR Newswire
01/10/2025

Pharming Group announces U.S. FDA acceptance and Priority Review of supplemental…

If approved, leniolisib will be first and only treatment indicated for children with activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS), a rare primary immunodeficiencyDecision based on positive data from multinational Phase III study in children aged 4 to 11 years with APDSPDUFA target action date of January 31, 2026Leiden, the Netherlands, October 1, 2025:Pharming Group N.V. (“Pharming” or “the Company”) (Euronext: PHARM; Nasdaq: PHAR) today announced...
Nasdaq GlobeNewswire
01/10/2025

TCL Unveils TCL ECORA™: A Game-Changing Material Made from Upcycled Ceramic…

Shane Lee, General Manager of TCL's Design Innovation Center, said: "Recycled ceramic has never been used in the consumer electronics industry, so TCL ECORA™ is totally unique. This eco-friendly solution enhances our products' performance and builds on our TCLGreen initiatives, empowering consumers to live healthier, more comfortable and eco-conscious lives." Shane Lee, General Manager of TCL's Design Innovation Center, said: "Recycled ceramic has never been used in the consumer…
PR Newswire
01/10/2025

HPV-Positive Oropharyngeal Cancer Market Poised for Strong Growth by 2034…

HPV+ Oropharyngeal Cancer Market Summary HPV+ Oropharyngeal Cancer Market Summary Discover the HPV+ oropharyngeal cancer new treatment @New Treatments for HPV+ Oropharyngeal Cancer Key Factors Driving the Growth of the HPV+ Oropharyngeal Cancer Market Rising incidence and shifting epidemiology The proportion of oropharyngeal cancers caused by HPV has increased substantially over the past two decades in many countries, producing a growing patient pool specifically labeled as…
PR Newswire
30/09/2025

University Health Network's Princess Margaret Cancer Centre Enters Research…

Upright radiotherapy is gaining renewed global attention for its potential to make advanced treatments such as proton therapy more accessible. By positioning the patient upright and rotating them in front of a fixed beam, rather than rotating a large, costly gantry, the approach has the potential to significantly reduce complexity and cost. Early research and patient feedback also suggest that upright treatment may offer a more comfortable and connected experience. Upright radiotherapy is...
PR Newswire
30/09/2025

Novartis receives FDA approval for Rhapsido® (remibrutinib), the only oral…

Ad hoc announcement pursuant to Art. 53 LR Rhapsido helps to inhibit release of histamine and proinflammatory mediators by targeting BTK, offering unique approach to CSU treatment1Well-controlled disease observed as fast as two weeks, with demonstrated safety profile that requires no lab monitoring1 1.7 million people in US live with CSU; more than half remain symptomatic despite increasing doses of antihistamines2,3Remibrutinib also in clinical development for ...
Nasdaq GlobeNewswire
30/09/2025

NANOBIOTIX Provides Business Update and Reports Half Year 2025 Financial Results

PARIS and CAMBRIDGE, Mass., Sept.30, 2025(GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO - NASDAQ: NBTX - the “Company”), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand treatment possibilities for patients with cancer and other major diseases, provided an update on operational progress and announced its half year financial results for the six-month period ended June 30, 2025. Operational Highlights of the 2025 Half Year Period and To Date ...
Nasdaq GlobeNewswire
30/09/2025

Full renewal of the Board of Directors Election of Dr. Markus Cappel as Chairman…

Full renewal of the Board of Directors Election of Dr. Markus Cappel as Chairman of the Board of DirectorsNantes, September 30, 2025, 7:30 p.m. CET – OSE Immunotherapeutics (ISIN: FR0012127173; Mnemonic: OSE)held its Annual General Meeting today in Paris and welcomed the participation of shareholders in this key moment for the company’s future. The shareholders who voted on the resolutions represented approximately 56% of OSE’s share capital and more than 62% of the voting rights...
Nasdaq GlobeNewswire
30/09/2025

AB Science announces a slight delay in the publication of its 2025 half-year…

PRESS RELEASEAB SCIENCE ANNOUNCES A SLIGHT DELAY IN THE PUBLICATION OF ITS 2025 HALF-YEAR FINANCIAL REPORTTHE COMPANY WILL PUBLISH ITS HALF-YEAR FINANCIAL REPORT FOR 2025 ON OCTOBER 10, 2025, AT THE LATESTParis, September 30 2025, 6.30pm CETAB Science SA(Euronext - FR0010557264 - AB) today announced that it has postponed the publication of its financial report for the first half of 2025, initially scheduled for 30 September 2025, to give the auditors time to complete their...
Nasdaq GlobeNewswire
30/09/2025

IPSEN - Buy-back programme - Art 5 of MAR - Week 39 - 2025

Aggregated presentation by day and by marketStatement of transactions in own shares from September 22nd to September 26th 2025 Name of the issueIdentity code of the issuer(Legal Entity Identifier) Day of the transactionIdentity code of the financial instrument Total daily volume (in number of shares)Daily weighted average purchase price of the sharesMarket (MIC Code) IPSEN549300M6SGDPB4Z94P1122/09/2025 ...
Nasdaq GlobeNewswire
30/09/2025

Oxurion maakt halfjaarresultaten 2025 bekend

Leuven, BELGIË – 30 September 2025 – 18:00 CET Oxurion NV (Euronext Brussel: OXUR) (de Vennootschap), een biofarmaceutisch bedrijf met hoofdkantoor in Leuven, maakt vandaag haar financiële en zakelijke update bekend voor het half jaar dat eindigde op 30 juni 2025. Het halfjaarverslag is beschikbaar in de rubriek 'Investeerders' op de website van de…
Actusnews Wire
30/09/2025

Oxurion Publishes First Half 2025 Results

Leuven, BELGIUM – September 30, 2025 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, published today its financial and business update for the six-month period ending June 30, 2025. The half-year report is available in the 'Investors' section of the Company's website and can also be…
Actusnews Wire
30/09/2025

Major Wellbeing Organization Selects Aino’s SaaS Platform

Aino Health AB (publ) has signed an agreement—facilitated through its occupational health collaboration partner Työterveys Aalto Occupational Health Care —with a leading wellbeing sector organization, covering 11,000 employees. The implementation of Aino’s SaaS platform is planned to begin within 2025, aiming to enhance proactive work ability management and employee well-being across the organization. “We are honored to support this organization in their mission to improve employee...
Nasdaq GlobeNewswire
30/09/2025

Sequana Medical’s alfapump® System Featured in Presentation at 2025 Portal…

, Sept.30, 2025(GLOBE NEWSWIRE) -- Dr. Rahul Patel of Icahn School of Medicine at Mount Sinai presented “alfapump®: Totally Implantable Peritoneal Drain Pump with Urinary Bladder Drainage” Ghent, Belgium – September 30, 2025–Sequana Medical NV (Euronext Brussels: SEQUA, the “Company” or “Sequana Medical”), a pioneer in the treatment of drug-resistant fluid overload in liver disease, heart failure and cancer, today announced that thealfa pump® System was featured in a podium...
Nasdaq GlobeNewswire
30/09/2025

Eternal Beauty Holdings Unveils 2025 China Perfume & Fragrance White Paper at…

Decoding China's "Scent Economy": New Pathways for Growth DecodingChina's"Scent Economy": New Pathways for Growth Amid global market fluctuations,China'sfragrance market stands out as a global growth engine and local resilience benchmark. It consistently outpaced other beauty categories in growth, demonstrating market stability. Male consumers and Gen Z from lower-tier cities are gradually unlocking their consumption potential, injecting fresh momentum into the market…
PR Newswire
30/09/2025
Altri  Comunicati